

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.77711431 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.77711431 |
| 3 | maternal placenta development (GO:0001893) | 4.70311799 |
| 4 | protein localization to endosome (GO:0036010) | 4.67620376 |
| 5 | pentose-phosphate shunt (GO:0006098) | 4.16813879 |
| 6 | skin morphogenesis (GO:0043589) | 4.14184318 |
| 7 | negative regulation of cell size (GO:0045792) | 4.11860607 |
| 8 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.06090880 |
| 9 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.00794379 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00685504 |
| 11 | cell-substrate junction assembly (GO:0007044) | 3.97005093 |
| 12 | regulation of cholesterol homeostasis (GO:2000188) | 3.93221872 |
| 13 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.84560039 |
| 14 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.82785938 |
| 15 | stress fiber assembly (GO:0043149) | 3.77229567 |
| 16 | positive regulation of histone deacetylation (GO:0031065) | 3.74020913 |
| 17 | barbed-end actin filament capping (GO:0051016) | 3.73889385 |
| 18 | regulation of translational fidelity (GO:0006450) | 3.73374557 |
| 19 | endodermal cell differentiation (GO:0035987) | 3.70515463 |
| 20 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.67687048 |
| 21 | glycine metabolic process (GO:0006544) | 3.64815232 |
| 22 | epithelial cell-cell adhesion (GO:0090136) | 3.57135292 |
| 23 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.55746561 |
| 24 | NADPH regeneration (GO:0006740) | 3.53422183 |
| 25 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.49068133 |
| 26 | lysine catabolic process (GO:0006554) | 3.48526427 |
| 27 | lysine metabolic process (GO:0006553) | 3.48526427 |
| 28 | semaphorin-plexin signaling pathway (GO:0071526) | 3.47076965 |
| 29 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.44189704 |
| 30 | hemidesmosome assembly (GO:0031581) | 3.41439158 |
| 31 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.38366594 |
| 32 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.35581918 |
| 33 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 3.31275245 |
| 34 | protein heterotrimerization (GO:0070208) | 3.30293323 |
| 35 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.22926378 |
| 36 | regulation of translational termination (GO:0006449) | 3.20857167 |
| 37 | 4-hydroxyproline metabolic process (GO:0019471) | 3.19324554 |
| 38 | atrioventricular valve morphogenesis (GO:0003181) | 3.16014075 |
| 39 | positive regulation of nuclease activity (GO:0032075) | 3.15750825 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 3.10789399 |
| 41 | negative regulation of sterol transport (GO:0032372) | 3.10558639 |
| 42 | negative regulation of cholesterol transport (GO:0032375) | 3.10558639 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 3.10494431 |
| 44 | DNA deamination (GO:0045006) | 3.06858157 |
| 45 | activation of MAPKKK activity (GO:0000185) | 3.06848300 |
| 46 | cell adhesion mediated by integrin (GO:0033627) | 3.04079324 |
| 47 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.03801440 |
| 48 | apoptotic process involved in morphogenesis (GO:0060561) | 3.02266001 |
| 49 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02049959 |
| 50 | negative regulation of fibrinolysis (GO:0051918) | 3.00463873 |
| 51 | galactose catabolic process (GO:0019388) | 2.96891599 |
| 52 | positive regulation of receptor recycling (GO:0001921) | 2.96110321 |
| 53 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.94602383 |
| 54 | peptidyl-lysine dimethylation (GO:0018027) | 2.90767982 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 2.90136878 |
| 56 | Golgi transport vesicle coating (GO:0048200) | 2.90136878 |
| 57 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.89850171 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.88566601 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 2.88566601 |
| 60 | positive regulation of protein deacetylation (GO:0090312) | 2.88102575 |
| 61 | adhesion of symbiont to host (GO:0044406) | 2.85136710 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 2.84854930 |
| 63 | virion attachment to host cell (GO:0019062) | 2.84854930 |
| 64 | glucose catabolic process (GO:0006007) | 2.84680223 |
| 65 | regulation of early endosome to late endosome transport (GO:2000641) | 2.84243128 |
| 66 | negative regulation of fatty acid transport (GO:2000192) | 2.84118178 |
| 67 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.83484797 |
| 68 | regulation of nuclease activity (GO:0032069) | 2.82694513 |
| 69 | cell migration involved in heart development (GO:0060973) | 2.82627645 |
| 70 | apoptotic cell clearance (GO:0043277) | 2.82261089 |
| 71 | urea cycle (GO:0000050) | 2.82251734 |
| 72 | urea metabolic process (GO:0019627) | 2.82251734 |
| 73 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.81426200 |
| 74 | regulation of gene silencing by miRNA (GO:0060964) | 2.81426200 |
| 75 | regulation of gene silencing by RNA (GO:0060966) | 2.81426200 |
| 76 | positive thymic T cell selection (GO:0045059) | 2.79352268 |
| 77 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.77425438 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 2.76613588 |
| 79 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.76524790 |
| 80 | endothelial cell chemotaxis (GO:0035767) | 2.76269742 |
| 81 | regulation of fatty acid oxidation (GO:0046320) | 2.75930483 |
| 82 | 2-oxoglutarate metabolic process (GO:0006103) | 2.75754243 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 2.75099954 |
| 84 | serine family amino acid catabolic process (GO:0009071) | 2.75093990 |
| 85 | regulation of cholesterol storage (GO:0010885) | 2.74768536 |
| 86 | peptidyl-proline hydroxylation (GO:0019511) | 2.74707836 |
| 87 | substrate-dependent cell migration (GO:0006929) | 2.73738381 |
| 88 | low-density lipoprotein particle clearance (GO:0034383) | 2.72494826 |
| 89 | protein maturation by protein folding (GO:0022417) | 2.72494408 |
| 90 | regulation of hippo signaling (GO:0035330) | 2.72366351 |
| 91 | endocytic recycling (GO:0032456) | 2.72261187 |
| 92 | negative regulation of lipid transport (GO:0032369) | 2.71779480 |
| 93 | cysteine metabolic process (GO:0006534) | 2.71763187 |
| 94 | mannose metabolic process (GO:0006013) | 2.71531716 |
| 95 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.70749111 |
| 96 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.69696104 |
| 97 | collagen fibril organization (GO:0030199) | 2.69017419 |
| 98 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.68853554 |
| 99 | protein retention in ER lumen (GO:0006621) | 2.68778140 |
| 100 | positive regulation of lamellipodium assembly (GO:0010592) | 2.66939929 |
| 101 | tetrahydrofolate metabolic process (GO:0046653) | 2.66806653 |
| 102 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.66185139 |
| 103 | actin filament bundle assembly (GO:0051017) | 2.65917831 |
| 104 | actin filament bundle organization (GO:0061572) | 2.65917831 |
| 105 | protein targeting to plasma membrane (GO:0072661) | 2.64988254 |
| 106 | collagen metabolic process (GO:0032963) | 2.64643249 |
| 107 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.63769334 |
| 108 | cell-cell junction maintenance (GO:0045217) | 2.63381946 |
| 109 | endothelial cell morphogenesis (GO:0001886) | 2.63014136 |
| 110 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.62066398 |
| 111 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.61987505 |
| 112 | actin filament depolymerization (GO:0030042) | 2.59609398 |
| 113 | nitrogen cycle metabolic process (GO:0071941) | 2.59560241 |
| 114 | extracellular fibril organization (GO:0043206) | 2.59070152 |
| 115 | one-carbon metabolic process (GO:0006730) | 2.58972013 |
| 116 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.58950354 |
| 117 | venous blood vessel morphogenesis (GO:0048845) | 2.58850318 |
| 118 | blood vessel endothelial cell migration (GO:0043534) | 2.56964147 |
| 119 | T cell apoptotic process (GO:0070231) | 2.56854637 |
| 120 | adherens junction assembly (GO:0034333) | 2.56205031 |
| 121 | negative regulation of catenin import into nucleus (GO:0035414) | 2.54483699 |
| 122 | wound healing, spreading of epidermal cells (GO:0035313) | 2.53276776 |
| 123 | regulation of extracellular matrix disassembly (GO:0010715) | 2.52777295 |
| 124 | cellular response to unfolded protein (GO:0034620) | 2.52703992 |
| 125 | heparan sulfate proteoglycan biosynthetic process (GO:0015012) | 2.52143567 |
| 126 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.51790121 |
| 127 | glyoxylate metabolic process (GO:0046487) | 2.51778461 |
| 128 | collagen catabolic process (GO:0030574) | 2.51441336 |
| 129 | glial cell migration (GO:0008347) | 2.51422821 |
| 130 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50743020 |
| 131 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.50709889 |
| 132 | tooth mineralization (GO:0034505) | 2.50375253 |
| 133 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.49827522 |
| 134 | cortical actin cytoskeleton organization (GO:0030866) | 2.49779934 |
| 135 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.49486743 |
| 136 | L-serine metabolic process (GO:0006563) | 2.49292909 |
| 137 | pinocytosis (GO:0006907) | 2.49237183 |
| 138 | heterochromatin organization (GO:0070828) | 2.49135590 |
| 139 | establishment of apical/basal cell polarity (GO:0035089) | 2.48553408 |
| 140 | positive regulation of fatty acid oxidation (GO:0046321) | 2.48409691 |
| 141 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.48334055 |
| 142 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.47513558 |
| 143 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.47414047 |
| 144 | viral transcription (GO:0019083) | 2.47199661 |
| 145 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.47162614 |
| 146 | response to laminar fluid shear stress (GO:0034616) | 2.46511657 |
| 147 | tricarboxylic acid metabolic process (GO:0072350) | 2.46105881 |
| 148 | protein hydroxylation (GO:0018126) | 2.44476954 |
| 149 | embryo implantation (GO:0007566) | 2.43646626 |
| 150 | aspartate family amino acid catabolic process (GO:0009068) | 2.43497825 |
| 151 | cochlea morphogenesis (GO:0090103) | 2.43394198 |
| 152 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.43107376 |
| 153 | fibril organization (GO:0097435) | 2.42186878 |
| 154 | ER-nucleus signaling pathway (GO:0006984) | 2.42123031 |
| 155 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.42066254 |
| 156 | cell-substrate adherens junction assembly (GO:0007045) | 2.41914309 |
| 157 | focal adhesion assembly (GO:0048041) | 2.41914309 |
| 158 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.41855716 |
| 159 | valine metabolic process (GO:0006573) | 2.41621808 |
| 160 | extracellular matrix disassembly (GO:0022617) | 2.41416354 |
| 161 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.41323615 |
| 162 | convergent extension (GO:0060026) | 2.41237754 |
| 163 | activation of Rac GTPase activity (GO:0032863) | 2.41133297 |
| 164 | adherens junction organization (GO:0034332) | 2.41061138 |
| 165 | wound healing, spreading of cells (GO:0044319) | 2.40842970 |
| 166 | basement membrane organization (GO:0071711) | 2.40794824 |
| 167 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.40553318 |
| 168 | oxaloacetate metabolic process (GO:0006107) | 2.40035908 |
| 169 | kynurenine metabolic process (GO:0070189) | 2.39885669 |
| 170 | translational termination (GO:0006415) | 2.39802568 |
| 171 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.38964045 |
| 172 | hyaluronan catabolic process (GO:0030214) | 2.35578706 |
| 173 | positive regulation of osteoblast proliferation (GO:0033690) | 2.35361746 |
| 174 | positive regulation of axon extension (GO:0045773) | 2.34333793 |
| 175 | regulation of establishment of planar polarity (GO:0090175) | 2.34089339 |
| 176 | bone trabecula formation (GO:0060346) | 2.32909734 |
| 177 | cellular response to nutrient (GO:0031670) | 2.30550955 |
| 178 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.30270242 |
| 179 | chondrocyte proliferation (GO:0035988) | 2.29948293 |
| 180 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.28615179 |
| 181 | multicellular organismal catabolic process (GO:0044243) | 2.27967612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.52702455 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.16902061 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95317879 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.81504971 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61114106 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.53194003 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.47192642 |
| 8 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.43772970 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.32838063 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.30013324 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27647902 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.20347252 |
| 13 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.15269060 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.97031710 |
| 15 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.96536934 |
| 16 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96000812 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91683099 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.89114599 |
| 19 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.87954622 |
| 20 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.87131388 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85035591 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.83770641 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.82947859 |
| 24 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.74961419 |
| 25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.74487796 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.73155119 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.71762297 |
| 28 | MAF_26560356_Chip-Seq_TH1_Human | 1.70112424 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.66815900 |
| 30 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.59291132 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.56967711 |
| 32 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.54742216 |
| 33 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.53235469 |
| 34 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.51993741 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.51391121 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50434065 |
| 37 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49536614 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48990532 |
| 39 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.48493897 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47656927 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41602428 |
| 42 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40695138 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40385464 |
| 44 | P68_20966046_ChIP-Seq_HELA_Human | 1.39403159 |
| 45 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.38770295 |
| 46 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38462010 |
| 47 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.35929031 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.34559321 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.34340248 |
| 50 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34140867 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.33274889 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.32960606 |
| 53 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31321941 |
| 54 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29704192 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29325840 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.29072949 |
| 57 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.26711477 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25950164 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25711366 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24675618 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23827916 |
| 62 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23821416 |
| 63 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23717036 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23676275 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22522128 |
| 66 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22300139 |
| 67 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21580452 |
| 68 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21135670 |
| 69 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19676424 |
| 70 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19628014 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19493135 |
| 72 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19075490 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19038716 |
| 74 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18926241 |
| 75 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.18110857 |
| 76 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.17877319 |
| 77 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17620437 |
| 78 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.17425694 |
| 79 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.17129272 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17077684 |
| 81 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.16601770 |
| 82 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16064156 |
| 83 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15006069 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14514823 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14443176 |
| 86 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.14148774 |
| 87 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13058172 |
| 88 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13038942 |
| 89 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.12298580 |
| 90 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10939342 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10573468 |
| 92 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10154288 |
| 93 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09539738 |
| 94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09477761 |
| 95 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.09302623 |
| 96 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08860516 |
| 97 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08860420 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08615403 |
| 99 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08447137 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08447137 |
| 101 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08421969 |
| 102 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07623057 |
| 103 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.07547775 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07539894 |
| 105 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07410627 |
| 106 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.07013250 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05607221 |
| 108 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03983728 |
| 109 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.02845408 |
| 110 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.02623233 |
| 111 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01832029 |
| 112 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.01398828 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01284742 |
| 114 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00828389 |
| 115 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00677371 |
| 116 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98748945 |
| 117 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98699322 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.98254482 |
| 119 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97769854 |
| 120 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97343321 |
| 121 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96840930 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.96331221 |
| 123 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95457175 |
| 124 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95299034 |
| 125 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95078176 |
| 126 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94629497 |
| 127 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.94433937 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94096970 |
| 129 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93864674 |
| 130 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93756684 |
| 131 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.93580557 |
| 132 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.93335593 |
| 133 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93168652 |
| 134 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.93015882 |
| 135 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92934358 |
| 136 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92276226 |
| 137 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91421475 |
| 138 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91312194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.92876628 |
| 2 | MP0009840_abnormal_foam_cell | 3.53049528 |
| 3 | MP0004272_abnormal_basement_membrane | 3.22268866 |
| 4 | MP0005360_urolithiasis | 3.02522482 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.99428663 |
| 6 | MP0000751_myopathy | 2.87742766 |
| 7 | MP0005083_abnormal_biliary_tract | 2.76173559 |
| 8 | MP0005257_abnormal_intraocular_pressure | 2.71960622 |
| 9 | MP0001958_emphysema | 2.49869474 |
| 10 | MP0005451_abnormal_body_composition | 2.40825539 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.39180771 |
| 12 | MP0005365_abnormal_bile_salt | 2.33535891 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.30313252 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.28829679 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.22793813 |
| 16 | MP0003303_peritoneal_inflammation | 2.22679174 |
| 17 | MP0002877_abnormal_melanocyte_morpholog | 2.18468373 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.18143600 |
| 19 | MP0005085_abnormal_gallbladder_physiolo | 2.15802591 |
| 20 | MP0010030_abnormal_orbit_morphology | 2.12326069 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.11021984 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.04738244 |
| 23 | MP0005275_abnormal_skin_tensile | 1.96712949 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.95613723 |
| 25 | MP0003252_abnormal_bile_duct | 1.79096003 |
| 26 | MP0000767_abnormal_smooth_muscle | 1.76645032 |
| 27 | MP0000685_abnormal_immune_system | 1.75029843 |
| 28 | MP0009384_cardiac_valve_regurgitation | 1.68874551 |
| 29 | MP0008260_abnormal_autophagy | 1.68293253 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.65086926 |
| 31 | MP0005023_abnormal_wound_healing | 1.62404898 |
| 32 | MP0000013_abnormal_adipose_tissue | 1.59128958 |
| 33 | MP0010329_abnormal_lipoprotein_level | 1.56372437 |
| 34 | MP0005503_abnormal_tendon_morphology | 1.56187775 |
| 35 | MP0002060_abnormal_skin_morphology | 1.52189477 |
| 36 | MP0000759_abnormal_skeletal_muscle | 1.50497522 |
| 37 | MP0000609_abnormal_liver_physiology | 1.48222968 |
| 38 | MP0000749_muscle_degeneration | 1.46252155 |
| 39 | MP0001542_abnormal_bone_strength | 1.41852289 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.41723300 |
| 41 | MP0001849_ear_inflammation | 1.40260557 |
| 42 | MP0005409_darkened_coat_color | 1.36767619 |
| 43 | MP0009278_abnormal_bone_marrow | 1.35599015 |
| 44 | MP0000733_abnormal_muscle_development | 1.34124982 |
| 45 | MP0010307_abnormal_tumor_latency | 1.29319469 |
| 46 | MP0001666_abnormal_nutrient_absorption | 1.29214100 |
| 47 | MP0005508_abnormal_skeleton_morphology | 1.26754961 |
| 48 | MP0003283_abnormal_digestive_organ | 1.25872355 |
| 49 | MP0002254_reproductive_system_inflammat | 1.25414747 |
| 50 | MP0004947_skin_inflammation | 1.22599476 |
| 51 | MP0002269_muscular_atrophy | 1.22035192 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.21470608 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.21117873 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.21055554 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.19649403 |
| 56 | MP0001730_embryonic_growth_arrest | 1.19380312 |
| 57 | MP0002896_abnormal_bone_mineralization | 1.19313600 |
| 58 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19029808 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.18482581 |
| 60 | MP0004510_myositis | 1.17595800 |
| 61 | MP0000678_abnormal_parathyroid_gland | 1.16765015 |
| 62 | MP0002796_impaired_skin_barrier | 1.15403230 |
| 63 | MP0003941_abnormal_skin_development | 1.14868911 |
| 64 | MP0000750_abnormal_muscle_regeneration | 1.13877200 |
| 65 | MP0000858_altered_metastatic_potential | 1.13446784 |
| 66 | MP0000598_abnormal_liver_morphology | 1.12919722 |
| 67 | MP0003436_decreased_susceptibility_to | 1.10970817 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.10195581 |
| 69 | MP0005501_abnormal_skin_physiology | 1.10194129 |
| 70 | MP0009053_abnormal_anal_canal | 1.09775542 |
| 71 | MP0004130_abnormal_muscle_cell | 1.09770398 |
| 72 | MP0000762_abnormal_tongue_morphology | 1.09526823 |
| 73 | MP0000537_abnormal_urethra_morphology | 1.08366325 |
| 74 | MP0005332_abnormal_amino_acid | 1.06838027 |
| 75 | MP0006138_congestive_heart_failure | 1.05654086 |
| 76 | MP0003091_abnormal_cell_migration | 1.04601970 |
| 77 | MP0002249_abnormal_larynx_morphology | 1.04186938 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.01579481 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.01544690 |
| 80 | MP0004087_abnormal_muscle_fiber | 1.01208511 |
| 81 | MP0005397_hematopoietic_system_phenotyp | 1.01127977 |
| 82 | MP0001545_abnormal_hematopoietic_system | 1.01127977 |
| 83 | MP0005595_abnormal_vascular_smooth | 0.99370734 |
| 84 | MP0003385_abnormal_body_wall | 0.99212968 |
| 85 | MP0004957_abnormal_blastocyst_morpholog | 0.98412358 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.97913219 |
| 87 | MP0005330_cardiomyopathy | 0.97689370 |
| 88 | MP0001915_intracranial_hemorrhage | 0.97027588 |
| 89 | MP0001879_abnormal_lymphatic_vessel | 0.96517606 |
| 90 | MP0001243_abnormal_dermal_layer | 0.95557585 |
| 91 | MP0004197_abnormal_fetal_growth/weight/ | 0.95010730 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.94390137 |
| 93 | MP0006054_spinal_hemorrhage | 0.93906751 |
| 94 | MP0003828_pulmonary_edema | 0.93887987 |
| 95 | MP0002089_abnormal_postnatal_growth/wei | 0.93494190 |
| 96 | MP0004233_abnormal_muscle_weight | 0.92852941 |
| 97 | MP0000604_amyloidosis | 0.92439674 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.92283253 |
| 99 | MP0004858_abnormal_nervous_system | 0.91819617 |
| 100 | MP0000534_abnormal_ureter_morphology | 0.91753654 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.91632898 |
| 102 | MP0000477_abnormal_intestine_morphology | 0.90756689 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.90618714 |
| 104 | MP0000747_muscle_weakness | 0.90499436 |
| 105 | MP0002080_prenatal_lethality | 0.90034603 |
| 106 | MP0000490_abnormal_crypts_of | 0.89688119 |
| 107 | MP0003329_amyloid_beta_deposits | 0.89512135 |
| 108 | MP0003693_abnormal_embryo_hatching | 0.88750014 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.88579665 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.87740132 |
| 111 | MP0010630_abnormal_cardiac_muscle | 0.87621979 |
| 112 | MP0003866_abnormal_defecation | 0.87359921 |
| 113 | MP0002108_abnormal_muscle_morphology | 0.87047879 |
| 114 | MP0004084_abnormal_cardiac_muscle | 0.86534320 |
| 115 | MP0002398_abnormal_bone_marrow | 0.86482857 |
| 116 | MP0005623_abnormal_meninges_morphology | 0.86381931 |
| 117 | MP0003453_abnormal_keratinocyte_physiol | 0.85068336 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.84375724 |
| 119 | MP0002722_abnormal_immune_system | 0.84174892 |
| 120 | MP0000343_altered_response_to | 0.83425905 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.83205236 |
| 122 | MP0005390_skeleton_phenotype | 0.83012313 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 0.82961100 |
| 124 | MP0003763_abnormal_thymus_physiology | 0.82926781 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.82611354 |
| 126 | MP0005165_increased_susceptibility_to | 0.82579796 |
| 127 | MP0002166_altered_tumor_susceptibility | 0.82416675 |
| 128 | MP0000689_abnormal_spleen_morphology | 0.82379077 |
| 129 | MP0001614_abnormal_blood_vessel | 0.82373885 |
| 130 | MP0002972_abnormal_cardiac_muscle | 0.82349506 |
| 131 | MP0002909_abnormal_adrenal_gland | 0.82028160 |
| 132 | MP0002295_abnormal_pulmonary_circulatio | 0.81722230 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.81490989 |
| 134 | MP0008770_decreased_survivor_rate | 0.80338639 |
| 135 | MP0002019_abnormal_tumor_incidence | 0.80117218 |
| 136 | MP0001873_stomach_inflammation | 0.79931798 |
| 137 | MP0002106_abnormal_muscle_physiology | 0.79025422 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78915487 |
| 139 | MP0000703_abnormal_thymus_morphology | 0.78746312 |
| 140 | MP0000467_abnormal_esophagus_morphology | 0.78494359 |
| 141 | MP0002332_abnormal_exercise_endurance | 0.78316166 |
| 142 | MP0003111_abnormal_nucleus_morphology | 0.77975859 |
| 143 | MP0003279_aneurysm | 0.77123690 |
| 144 | MP0003634_abnormal_glial_cell | 0.76170973 |
| 145 | MP0003942_abnormal_urinary_system | 0.75958636 |
| 146 | MP0002088_abnormal_embryonic_growth/wei | 0.75749060 |
| 147 | MP0002138_abnormal_hepatobiliary_system | 0.75703811 |
| 148 | MP0003984_embryonic_growth_retardation | 0.75577164 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75106847 |
| 150 | MP0009672_abnormal_birth_weight | 0.74985250 |
| 151 | MP0005621_abnormal_cell_physiology | 0.74892722 |
| 152 | MP0005620_abnormal_muscle_contractility | 0.74404363 |
| 153 | MP0000579_abnormal_nail_morphology | 0.73105037 |
| 154 | MP0000358_abnormal_cell_content/ | 0.71877665 |
| 155 | MP0005369_muscle_phenotype | 0.71604993 |
| 156 | MP0008469_abnormal_protein_level | 0.71553976 |
| 157 | MP0002429_abnormal_blood_cell | 0.71348208 |
| 158 | MP0000003_abnormal_adipose_tissue | 0.71215288 |
| 159 | MP0004859_abnormal_synaptic_plasticity | 0.69507803 |
| 160 | MP0002128_abnormal_blood_circulation | 0.68774826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 3.58986682 |
| 2 | Spinal rigidity (HP:0003306) | 3.40310344 |
| 3 | Abnormality of the Achilles tendon (HP:0005109) | 3.37759748 |
| 4 | Achilles tendon contracture (HP:0001771) | 3.31588102 |
| 5 | Distal lower limb muscle weakness (HP:0009053) | 3.31190684 |
| 6 | Deep venous thrombosis (HP:0002625) | 3.26312171 |
| 7 | Atrophic scars (HP:0001075) | 3.25021400 |
| 8 | Distal lower limb amyotrophy (HP:0008944) | 3.23028845 |
| 9 | Cerebral aneurysm (HP:0004944) | 3.22731379 |
| 10 | Hyperacusis (HP:0010780) | 3.19736072 |
| 11 | Fragile skin (HP:0001030) | 3.15921736 |
| 12 | Increased variability in muscle fiber diameter (HP:0003557) | 3.15163051 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.09747572 |
| 14 | Xanthomatosis (HP:0000991) | 3.00966337 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.94392527 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.92616975 |
| 17 | Upper limb amyotrophy (HP:0009129) | 2.86747808 |
| 18 | Distal upper limb amyotrophy (HP:0007149) | 2.86747808 |
| 19 | Aortic dissection (HP:0002647) | 2.83625671 |
| 20 | Hand muscle atrophy (HP:0009130) | 2.65166951 |
| 21 | Vascular tortuosity (HP:0004948) | 2.62211139 |
| 22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.56447178 |
| 23 | Mitral regurgitation (HP:0001653) | 2.55949653 |
| 24 | Blue sclerae (HP:0000592) | 2.55188667 |
| 25 | Arterial tortuosity (HP:0005116) | 2.49737249 |
| 26 | Wormian bones (HP:0002645) | 2.49689375 |
| 27 | Lower limb amyotrophy (HP:0007210) | 2.49223557 |
| 28 | Round ear (HP:0100830) | 2.49170396 |
| 29 | Shallow orbits (HP:0000586) | 2.47464812 |
| 30 | Spastic diplegia (HP:0001264) | 2.46046464 |
| 31 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.45104266 |
| 32 | Long toe (HP:0010511) | 2.41886956 |
| 33 | Genu recurvatum (HP:0002816) | 2.39697103 |
| 34 | Abnormality of dentin (HP:0010299) | 2.39160453 |
| 35 | Short nail (HP:0001799) | 2.32539586 |
| 36 | Soft skin (HP:0000977) | 2.29324054 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 2.28829919 |
| 38 | Aneurysm (HP:0002617) | 2.28587223 |
| 39 | Disproportionate tall stature (HP:0001519) | 2.26760364 |
| 40 | Abnormality of the lower motor neuron (HP:0002366) | 2.25484466 |
| 41 | Slender build (HP:0001533) | 2.24974925 |
| 42 | Pseudobulbar signs (HP:0002200) | 2.23615426 |
| 43 | Increased connective tissue (HP:0009025) | 2.23393532 |
| 44 | Nasal polyposis (HP:0100582) | 2.22800766 |
| 45 | Neonatal short-limb short stature (HP:0008921) | 2.21582786 |
| 46 | Mitral valve prolapse (HP:0001634) | 2.21494034 |
| 47 | Ankle contracture (HP:0006466) | 2.20939687 |
| 48 | Difficulty climbing stairs (HP:0003551) | 2.20198275 |
| 49 | Broad face (HP:0000283) | 2.19492714 |
| 50 | Adenoma sebaceum (HP:0009720) | 2.17387545 |
| 51 | Angiofibromas (HP:0010615) | 2.17387545 |
| 52 | Insomnia (HP:0100785) | 2.16272120 |
| 53 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.16129212 |
| 54 | Biconcave vertebral bodies (HP:0004586) | 2.14763872 |
| 55 | Reticulocytosis (HP:0001923) | 2.14728738 |
| 56 | Hyperammonemia (HP:0001987) | 2.13991953 |
| 57 | Long palpebral fissure (HP:0000637) | 2.11708345 |
| 58 | Myopathic facies (HP:0002058) | 2.11391465 |
| 59 | Back pain (HP:0003418) | 2.11158823 |
| 60 | Elbow flexion contracture (HP:0002987) | 2.11123944 |
| 61 | Thin bony cortex (HP:0002753) | 2.08829262 |
| 62 | Asymmetric septal hypertrophy (HP:0001670) | 2.08407252 |
| 63 | Hypobetalipoproteinemia (HP:0003563) | 2.07855328 |
| 64 | Radial bowing (HP:0002986) | 2.07477200 |
| 65 | Natal tooth (HP:0000695) | 2.05691573 |
| 66 | Ketosis (HP:0001946) | 2.03794435 |
| 67 | Muscle fiber inclusion bodies (HP:0100299) | 2.03788108 |
| 68 | Increased density of long bones (HP:0006392) | 2.02471469 |
| 69 | Polycythemia (HP:0001901) | 2.02085628 |
| 70 | Intrahepatic cholestasis (HP:0001406) | 2.00376505 |
| 71 | Hyperextensible skin (HP:0000974) | 1.99753504 |
| 72 | Stridor (HP:0010307) | 1.99683164 |
| 73 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.99458348 |
| 74 | Frequent falls (HP:0002359) | 1.98579624 |
| 75 | Obstructive sleep apnea (HP:0002870) | 1.98371432 |
| 76 | Bowing of the arm (HP:0006488) | 1.96996838 |
| 77 | Bowed forearm bones (HP:0003956) | 1.96996838 |
| 78 | Global brain atrophy (HP:0002283) | 1.96357741 |
| 79 | Premature rupture of membranes (HP:0001788) | 1.95955401 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 1.95825343 |
| 81 | Lymphangioma (HP:0100764) | 1.95453173 |
| 82 | Flat acetabular roof (HP:0003180) | 1.95248908 |
| 83 | Hypercortisolism (HP:0001578) | 1.94423178 |
| 84 | Joint laxity (HP:0001388) | 1.93345480 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 1.93039270 |
| 86 | Nemaline bodies (HP:0003798) | 1.92848237 |
| 87 | Trismus (HP:0000211) | 1.91336694 |
| 88 | Hyporeflexia of lower limbs (HP:0002600) | 1.91112380 |
| 89 | Renovascular hypertension (HP:0100817) | 1.90907985 |
| 90 | Myoglobinuria (HP:0002913) | 1.89690742 |
| 91 | Elfin facies (HP:0004428) | 1.88615336 |
| 92 | Progressive muscle weakness (HP:0003323) | 1.88492252 |
| 93 | Late onset (HP:0003584) | 1.88424049 |
| 94 | Ulnar bowing (HP:0003031) | 1.88185120 |
| 95 | Ulnar deviation of the wrist (HP:0003049) | 1.87766694 |
| 96 | Deep palmar crease (HP:0006191) | 1.87728495 |
| 97 | Complement deficiency (HP:0004431) | 1.87699530 |
| 98 | Ependymoma (HP:0002888) | 1.85914896 |
| 99 | Cervical subluxation (HP:0003308) | 1.85468265 |
| 100 | Peritonitis (HP:0002586) | 1.85129084 |
| 101 | Scapular winging (HP:0003691) | 1.83338872 |
| 102 | Myocardial infarction (HP:0001658) | 1.81848480 |
| 103 | Type 1 muscle fiber predominance (HP:0003803) | 1.79933915 |
| 104 | Hypolipoproteinemia (HP:0010981) | 1.78597308 |
| 105 | Multiple enchondromatosis (HP:0005701) | 1.78118646 |
| 106 | Joint stiffness (HP:0001387) | 1.78032969 |
| 107 | Exercise-induced myalgia (HP:0003738) | 1.77392825 |
| 108 | Abnormality of complement system (HP:0005339) | 1.77266969 |
| 109 | Hypoalphalipoproteinemia (HP:0003233) | 1.77078368 |
| 110 | Muscle fiber splitting (HP:0003555) | 1.76932940 |
| 111 | Rhabdomyolysis (HP:0003201) | 1.76798409 |
| 112 | Cerebral inclusion bodies (HP:0100314) | 1.76526237 |
| 113 | Hypoventilation (HP:0002791) | 1.76519409 |
| 114 | Increased serum ferritin (HP:0003281) | 1.76302080 |
| 115 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76116368 |
| 116 | Abnormality of the calcaneus (HP:0008364) | 1.75814343 |
| 117 | Bowel diverticulosis (HP:0005222) | 1.75792931 |
| 118 | Follicular hyperkeratosis (HP:0007502) | 1.75607758 |
| 119 | Thin ribs (HP:0000883) | 1.74959469 |
| 120 | Spondylolisthesis (HP:0003302) | 1.74171695 |
| 121 | Aortic regurgitation (HP:0001659) | 1.73423788 |
| 122 | Renal duplication (HP:0000075) | 1.72919209 |
| 123 | Neonatal onset (HP:0003623) | 1.72161006 |
| 124 | Nuclear cataract (HP:0100018) | 1.71874916 |
| 125 | Wrist flexion contracture (HP:0001239) | 1.71631404 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70829268 |
| 127 | Osteolytic defects of the hand bones (HP:0009699) | 1.70829268 |
| 128 | Abnormality of the acetabulum (HP:0003170) | 1.70208876 |
| 129 | Polygenic inheritance (HP:0010982) | 1.69904280 |
| 130 | Striae distensae (HP:0001065) | 1.69577598 |
| 131 | Bladder diverticulum (HP:0000015) | 1.69406536 |
| 132 | Ventricular tachycardia (HP:0004756) | 1.68738355 |
| 133 | Axonal loss (HP:0003447) | 1.68680101 |
| 134 | Interstitial pulmonary disease (HP:0006530) | 1.67900493 |
| 135 | Nonimmune hydrops fetalis (HP:0001790) | 1.67631727 |
| 136 | Abnormal platelet function (HP:0011869) | 1.67240360 |
| 137 | Impaired platelet aggregation (HP:0003540) | 1.67240360 |
| 138 | Limb-girdle muscle atrophy (HP:0003797) | 1.67114370 |
| 139 | Abnormal neuron morphology (HP:0012757) | 1.66744049 |
| 140 | Abnormality of the motor neurons (HP:0002450) | 1.66744049 |
| 141 | Hyperparathyroidism (HP:0000843) | 1.66653157 |
| 142 | Neurofibrillary tangles (HP:0002185) | 1.66141475 |
| 143 | Thrombocytosis (HP:0001894) | 1.65568284 |
| 144 | Abnormal cartilage morphology (HP:0002763) | 1.65493114 |
| 145 | Esophageal varix (HP:0002040) | 1.65060481 |
| 146 | Cholelithiasis (HP:0001081) | 1.64667555 |
| 147 | Papilloma (HP:0012740) | 1.64527395 |
| 148 | Verrucae (HP:0200043) | 1.64527395 |
| 149 | Gastrointestinal inflammation (HP:0004386) | 1.64383589 |
| 150 | Basal cell carcinoma (HP:0002671) | 1.63153512 |
| 151 | Turricephaly (HP:0000262) | 1.62773231 |
| 152 | Ectopia lentis (HP:0001083) | 1.62662092 |
| 153 | Fibroma (HP:0010614) | 1.60917682 |
| 154 | Selective tooth agenesis (HP:0001592) | 1.60687319 |
| 155 | Congenital glaucoma (HP:0001087) | 1.60294350 |
| 156 | Severe short stature (HP:0003510) | 1.60175657 |
| 157 | Abnormality of the tricuspid valve (HP:0001702) | 1.59593947 |
| 158 | Coxa vara (HP:0002812) | 1.59536975 |
| 159 | Broad metatarsal (HP:0001783) | 1.58886182 |
| 160 | Aortic aneurysm (HP:0004942) | 1.58759898 |
| 161 | Generalized amyotrophy (HP:0003700) | 1.58613937 |
| 162 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.58441198 |
| 163 | Abnormality of iron homeostasis (HP:0011031) | 1.57572460 |
| 164 | Recurrent bronchitis (HP:0002837) | 1.55926630 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.89491572 |
| 2 | PKN2 | 4.00746212 |
| 3 | ERN1 | 3.96567096 |
| 4 | EEF2K | 3.36098366 |
| 5 | MAP3K10 | 3.12780769 |
| 6 | SMG1 | 2.66336875 |
| 7 | PRPF4B | 2.26644790 |
| 8 | IRAK3 | 2.22774700 |
| 9 | MAP4K1 | 2.21118438 |
| 10 | SIK1 | 2.13182736 |
| 11 | TESK2 | 2.04717682 |
| 12 | BCKDK | 2.03103694 |
| 13 | SCYL2 | 2.01563801 |
| 14 | TTN | 1.97401849 |
| 15 | ICK | 1.91709931 |
| 16 | LRRK2 | 1.89251492 |
| 17 | PTK6 | 1.83069724 |
| 18 | RIPK1 | 1.78070103 |
| 19 | NTRK1 | 1.77546392 |
| 20 | ARAF | 1.76849111 |
| 21 | MYLK | 1.74087534 |
| 22 | TAOK2 | 1.59871900 |
| 23 | FLT3 | 1.59157638 |
| 24 | FGFR4 | 1.58145353 |
| 25 | TLK1 | 1.56213002 |
| 26 | KDR | 1.52394423 |
| 27 | EPHA2 | 1.49583236 |
| 28 | CDK12 | 1.43250519 |
| 29 | TESK1 | 1.42023344 |
| 30 | PDGFRA | 1.41454313 |
| 31 | NEK1 | 1.38744698 |
| 32 | MOS | 1.27306137 |
| 33 | CDC42BPA | 1.26967817 |
| 34 | TBK1 | 1.26657070 |
| 35 | PAK4 | 1.26625802 |
| 36 | PRKD2 | 1.25503658 |
| 37 | ALK | 1.22064942 |
| 38 | KSR2 | 1.21856354 |
| 39 | NEK2 | 1.21464135 |
| 40 | MAP3K3 | 1.19435874 |
| 41 | MAP3K11 | 1.18470231 |
| 42 | NME2 | 1.17576440 |
| 43 | TAOK1 | 1.17278324 |
| 44 | ZAP70 | 1.14045433 |
| 45 | BMX | 1.13545934 |
| 46 | GRK6 | 1.12910481 |
| 47 | STK10 | 1.12008189 |
| 48 | MTOR | 1.06647282 |
| 49 | MAP3K8 | 1.02654253 |
| 50 | BRAF | 1.02188079 |
| 51 | MAP2K2 | 1.01774081 |
| 52 | MAPKAPK3 | 0.97415194 |
| 53 | MAP3K7 | 0.95563966 |
| 54 | BUB1 | 0.93402383 |
| 55 | ILK | 0.93301934 |
| 56 | TYK2 | 0.93141615 |
| 57 | RPS6KB2 | 0.92775744 |
| 58 | MAP3K6 | 0.92466523 |
| 59 | MAP2K3 | 0.89825461 |
| 60 | PTK2 | 0.89776645 |
| 61 | PAK2 | 0.88688482 |
| 62 | BLK | 0.85561024 |
| 63 | MAP3K13 | 0.85480466 |
| 64 | DYRK1B | 0.83662631 |
| 65 | MET | 0.83359792 |
| 66 | JAK3 | 0.78536534 |
| 67 | ABL2 | 0.77609205 |
| 68 | DDR2 | 0.77265979 |
| 69 | MAPK11 | 0.77258891 |
| 70 | CDK4 | 0.74318978 |
| 71 | STK38 | 0.73742103 |
| 72 | DMPK | 0.72307927 |
| 73 | TIE1 | 0.72023310 |
| 74 | LMTK2 | 0.70334732 |
| 75 | MST1R | 0.69551954 |
| 76 | PRKD3 | 0.68989331 |
| 77 | CAMKK1 | 0.68193751 |
| 78 | RET | 0.67839751 |
| 79 | EPHB1 | 0.67678489 |
| 80 | RPS6KA4 | 0.65531477 |
| 81 | ROCK2 | 0.65098635 |
| 82 | LATS2 | 0.64342065 |
| 83 | JAK2 | 0.62576746 |
| 84 | PRKG2 | 0.62558168 |
| 85 | NEK9 | 0.60348826 |
| 86 | CSF1R | 0.56640844 |
| 87 | LIMK1 | 0.56550859 |
| 88 | BTK | 0.55856722 |
| 89 | CSK | 0.55025515 |
| 90 | PAK6 | 0.54262085 |
| 91 | AKT2 | 0.53470206 |
| 92 | HCK | 0.52497930 |
| 93 | TYRO3 | 0.52476003 |
| 94 | MAPK12 | 0.49905614 |
| 95 | EPHB2 | 0.49439300 |
| 96 | TGFBR2 | 0.48346318 |
| 97 | MAP3K1 | 0.47629540 |
| 98 | PAK1 | 0.47015515 |
| 99 | CAMK2G | 0.46433731 |
| 100 | JAK1 | 0.46304628 |
| 101 | CAMK1D | 0.45147985 |
| 102 | PIM1 | 0.44553622 |
| 103 | HIPK2 | 0.43874399 |
| 104 | RPS6KA1 | 0.43010803 |
| 105 | TGFBR1 | 0.41192286 |
| 106 | MARK2 | 0.40500650 |
| 107 | ERBB4 | 0.39438175 |
| 108 | MAP2K1 | 0.39210606 |
| 109 | CDK11A | 0.38464975 |
| 110 | MAPK7 | 0.36872811 |
| 111 | CDK6 | 0.36639620 |
| 112 | CDK7 | 0.35834193 |
| 113 | * DAPK3 | 0.35786602 |
| 114 | * ROCK1 | 0.35683844 |
| 115 | PRKD1 | 0.35366324 |
| 116 | MAP3K9 | 0.34973424 |
| 117 | CDK15 | 0.34784227 |
| 118 | SIK2 | 0.34609074 |
| 119 | PDGFRB | 0.33689822 |
| 120 | MAPK4 | 0.33395523 |
| 121 | PIM2 | 0.32251193 |
| 122 | PDPK1 | 0.32183195 |
| 123 | TRPM7 | 0.32165942 |
| 124 | PDK1 | 0.29793196 |
| 125 | AURKA | 0.29331243 |
| 126 | MAPKAPK2 | 0.29197526 |
| 127 | RPS6KL1 | 0.28773031 |
| 128 | RPS6KC1 | 0.28773031 |
| 129 | CDK18 | 0.28101702 |
| 130 | CDK14 | 0.28027981 |
| 131 | RPS6KA6 | 0.27837957 |
| 132 | RPS6KA2 | 0.26584476 |
| 133 | PRKCI | 0.25877384 |
| 134 | IKBKE | 0.25854304 |
| 135 | FGFR1 | 0.25620053 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23498074 |
| 2 | Sulfur relay system_Homo sapiens_hsa04122 | 3.22250165 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.15251964 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36316298 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.35264956 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.18905442 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.13552199 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08648819 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.08381000 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05495528 |
| 11 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.01972263 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87538678 |
| 13 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.86550720 |
| 14 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.81334044 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79377200 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.74591910 |
| 17 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.69970066 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.68948991 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.68832055 |
| 20 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.66409684 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65933800 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.65299696 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41183997 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.40840973 |
| 25 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.38124503 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36009513 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29871512 |
| 28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29434118 |
| 29 | * Bladder cancer_Homo sapiens_hsa05219 | 1.28981691 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27020214 |
| 31 | Adherens junction_Homo sapiens_hsa04520 | 1.23779559 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20457633 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.19731528 |
| 34 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19586681 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.18613532 |
| 36 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.18197398 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18035120 |
| 38 | Lysine degradation_Homo sapiens_hsa00310 | 1.16542726 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15632964 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.14322454 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12667749 |
| 42 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.12299299 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11441714 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.11273065 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.11105847 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10755976 |
| 47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.08364314 |
| 48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06576966 |
| 49 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.05187901 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.05079861 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04856643 |
| 52 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03326885 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03232839 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.03066690 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02592635 |
| 56 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01653607 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00054192 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 0.99928589 |
| 59 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.99243738 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99236298 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98751691 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.98252473 |
| 63 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97566825 |
| 64 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97013936 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.96629305 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.94282547 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.94085707 |
| 68 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.93690260 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92509919 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92304681 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91730496 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.90344113 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.89621590 |
| 74 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.88630364 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88463660 |
| 76 | Axon guidance_Homo sapiens_hsa04360 | 0.88149516 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85286633 |
| 78 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83082131 |
| 79 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.81480175 |
| 80 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81390485 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81233185 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.81098029 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.80642543 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78644583 |
| 85 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78438617 |
| 86 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.77932836 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.76011415 |
| 88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75453528 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.74188087 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.72651387 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72362349 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.72222505 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71625304 |
| 94 | DNA replication_Homo sapiens_hsa03030 | 0.70869577 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70716933 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.70680352 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.70417098 |
| 98 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69612044 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68692359 |
| 100 | Hepatitis C_Homo sapiens_hsa05160 | 0.67988954 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.67808255 |
| 102 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.67444888 |
| 103 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.66527698 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65976616 |
| 105 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65917523 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65805448 |
| 107 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.65774090 |
| 108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65610432 |
| 109 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.65578321 |
| 110 | Melanoma_Homo sapiens_hsa05218 | 0.64874919 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64561914 |
| 112 | Malaria_Homo sapiens_hsa05144 | 0.63726743 |
| 113 | Hepatitis B_Homo sapiens_hsa05161 | 0.63702092 |
| 114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.63364104 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.63325488 |
| 116 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63322462 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.61762099 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61326356 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61078250 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60715782 |
| 121 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60218657 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.59799055 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58603349 |
| 124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58394306 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.56827597 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.56162220 |
| 127 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55968812 |
| 128 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55563132 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54390690 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.54380769 |
| 131 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53370195 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52395594 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52166993 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51935419 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.51805463 |
| 136 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.51750282 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.51680166 |
| 138 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.50951545 |
| 139 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48835717 |
| 140 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45533399 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.44680736 |
| 142 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43223179 |
| 143 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42311277 |
| 144 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40463412 |
| 145 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40299627 |
| 146 | ABC transporters_Homo sapiens_hsa02010 | 0.39940926 |
| 147 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.39684714 |
| 148 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39219617 |
| 149 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38652689 |
| 150 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38081235 |

